Pharming Shares Fall After FDA Sends Complete Response Letter on Pediatric sNDA for Joenja
Pharming Group NV shares dropped sharply in premarket trading after the U.S. Food and Drug Administration issued a Complete Response Letter for the supplemental New Drug Application for Joenja, citing concerns about possible underexposure in lower weight pediatric patients and problems with an analytical method used in production batch testing. The…